
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12057176
[patent_doc_number] => 20170333520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS INVOLVING EPITHELIAL CELL APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/606699
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27612
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606699 | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis | May 25, 2017 | Issued |
Array
(
[id] => 11955093
[patent_doc_number] => 20170259244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Chromatography Ligand Comprising Domain C From Staphylococcus Aureus Protein A For Antibody Isolation'
[patent_app_type] => utility
[patent_app_number] => 15/603285
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603285 | Chromatography ligand comprising domain C from | May 22, 2017 | Issued |
Array
(
[id] => 11949487
[patent_doc_number] => 20170253637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/599441
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20734
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599441
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599441 | SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF | May 17, 2017 | Abandoned |
Array
(
[id] => 16328359
[patent_doc_number] => 20200299325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => Method of Cleaning and/or Sanitizing a Separation Matrix
[patent_app_type] => utility
[patent_app_number] => 16/095753
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095753 | Method of cleaning and/or sanitizing a separation matrix | May 9, 2017 | Issued |
Array
(
[id] => 12015831
[patent_doc_number] => 09808519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Composition for inducing proliferation or accumulation of regulatory T cells'
[patent_app_type] => utility
[patent_app_number] => 15/590257
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 53
[patent_no_of_words] => 23119
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590257 | Composition for inducing proliferation or accumulation of regulatory T cells | May 8, 2017 | Issued |
Array
(
[id] => 13139845
[patent_doc_number] => 10087243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Compositions and methods for phagocyte delivery of anti-staphylococcal agents
[patent_app_type] => utility
[patent_app_number] => 15/584235
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 40776
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15584235
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/584235 | Compositions and methods for phagocyte delivery of anti-staphylococcal agents | May 1, 2017 | Issued |
Array
(
[id] => 11866508
[patent_doc_number] => 20170233793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Borrellia Provocation Procedure Protocol'
[patent_app_type] => utility
[patent_app_number] => 15/581550
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9045
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581550 | Borrellia provocation procedure protocol | Apr 27, 2017 | Issued |
Array
(
[id] => 11986746
[patent_doc_number] => 20170290901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'GLOBAL GENE REGULATORS (GGR) AS VACCINE CANDIDATES AGAINST PARATUBERCULOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/492553
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28083
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492553 | Global gene regulators (GGR) as vaccine candidates against | Apr 19, 2017 | Issued |
Array
(
[id] => 11992489
[patent_doc_number] => 20170296644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'METHODS FOR TREATING PLAGUE'
[patent_app_type] => utility
[patent_app_number] => 15/490261
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 20824
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490261
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490261 | Methods for treating plague | Apr 17, 2017 | Issued |
Array
(
[id] => 15469067
[patent_doc_number] => 10550398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => RlmA-inactivated filamentous fungal host cell
[patent_app_type] => utility
[patent_app_number] => 16/094795
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10358
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094795 | RlmA-inactivated filamentous fungal host cell | Apr 17, 2017 | Issued |
Array
(
[id] => 15574051
[patent_doc_number] => 10577392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Capture purification processes for proteins expressed in a non-mammalian system
[patent_app_type] => utility
[patent_app_number] => 15/476691
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11963
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476691 | Capture purification processes for proteins expressed in a non-mammalian system | Mar 30, 2017 | Issued |
Array
(
[id] => 11864759
[patent_doc_number] => 20170232045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/472871
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 23120
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472871
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472871 | Composition for inducing proliferation or accumulation of regulatory T cells | Mar 28, 2017 | Issued |
Array
(
[id] => 12924688
[patent_doc_number] => 09827276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Composition for inducing proliferation or accumulation of regulatory T cells
[patent_app_type] => utility
[patent_app_number] => 15/472840
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 53
[patent_no_of_words] => 22085
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472840 | Composition for inducing proliferation or accumulation of regulatory T cells | Mar 28, 2017 | Issued |
Array
(
[id] => 16430695
[patent_doc_number] => 10830774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Methods and compositions for diagnosis and treatment of meningitis
[patent_app_type] => utility
[patent_app_number] => 15/469986
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21478
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469986 | Methods and compositions for diagnosis and treatment of meningitis | Mar 26, 2017 | Issued |
| 15/465264 | ANTIBODY | Mar 20, 2017 | Abandoned |
Array
(
[id] => 11963611
[patent_doc_number] => 20170267764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'ANTI-MICA ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/458123
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22960
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458123 | ANTI-MICA ANTIBODIES | Mar 13, 2017 | Abandoned |
Array
(
[id] => 11954733
[patent_doc_number] => 20170258885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'FUSION PROTEIN COMPRISING STREPTOCOCCAL ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 15/457720
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9693
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457720 | FUSION PROTEIN COMPRISING STREPTOCOCCAL ANTIGEN | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14040833
[patent_doc_number] => 20190076523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA
[patent_app_type] => utility
[patent_app_number] => 16/085234
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085234 | TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14159163
[patent_doc_number] => 20190106684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => MODIFIED CELL
[patent_app_type] => utility
[patent_app_number] => 16/082383
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082383 | MODIFIED CELL | Mar 12, 2017 | Abandoned |
Array
(
[id] => 11954728
[patent_doc_number] => 20170258879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'METHOD OF TREATING SEASONAL AFFECTIVE DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/455032
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10649
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455032
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455032 | METHOD OF TREATING SEASONAL AFFECTIVE DISORDER | Mar 8, 2017 | Abandoned |